Down-regulation of Key Regulatory Factors in Sphingosine-1-phosphate (S1P) Pathway in Human Lung Fibroblasts Transfected with Selected MicroRNAs

Overview

Journal Mol Biol Res Commun

Specialty Molecular Biology

Date 2024 Sep 24

PMID 39315290

Authors

Abdolamir Allameh

Mostafa Atashbasteh

Esmaeil Mortaz

Bahareh Naeeni

Majid Jafari-Khorchani

Affiliations

Soon will be listed here.

Abstract

Sphingosine 1 phosphate (S1P) is involved in the pathogenesis of asthma by stimulation of the alpha-smooth muscle actin (SMA) expression and remodeling of fibroblasts. This study was designed to determine the effects of selected micro RNAs in regulation of S1P and related metabolic pathways in a human lung fibroblast cell line. The fibroblast cell line (CIRC-HLF, C580) was cultured and transfected with individual viral vectors carrying miR124, mi125b, mi133b or mi130a. After 48 hours, expression level of miRNAs and their target genes, sphingosine kinase 1(SPHK1), sphingosine 1-phosphate lyase 1 (SGPL1), sphingosine 1- phosphate receptor 1 (S1PR1) and sphingosine 1- phosphate receptor 2 (S1PR2) were determined. Expression of miRNA and mRNA determined by reverse transcriptionquantitative polymerase chain reaction (qPCR) showed that the expression level of the miRNAs was significantly higher in human lung fibroblasts following transfection compared to controls (vector backbone without miRNA). The expressions of miRNAs-targeted genes were significantly downregulated in transfected fibroblasts compared to control cells (p<0.05). Data show that miR 124, miR 125b, miR 133b and miR130a by targeting regulatory genes in S1P-pathway can down-regulate key factors such as SPHK1, SGPL1, S1PR1 and S1PR2 genes in lung fibroblasts. The results showed that S1P pathway and key factors are suppressed in lung fibroblasts expressing miR124, miR125b, miR130a or miR133b. It appears that suppression of any of the intermediate factors in S1P by miRNA can affect the regulation of the entire S1P pathway.

References

Carthew R . Gene regulation by microRNAs. Curr Opin Genet Dev. 2006; 16(2):203-8. DOI: 10.1016/j.gde.2006.02.012. View

Kunita A, Morita S, Irisa T, Goto A, Niki T, Takai D . MicroRNA-21 in cancer-associated fibroblasts supports lung adenocarcinoma progression. Sci Rep. 2018; 8(1):8838. PMC: 5995955. DOI: 10.1038/s41598-018-27128-3. View

Sobel K, Menyhart K, Killer N, Renault B, Bauer Y, Studer R . Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling. J Biol Chem. 2013; 288(21):14839-51. PMC: 3663507. DOI: 10.1074/jbc.M112.426726. View

Zhang Y, Cai H, Chen S, Sun D, Zhang D, He Y . Exosomal transfer of miR-124 inhibits normal fibroblasts to cancer-associated fibroblasts transition by targeting sphingosine kinase 1 in ovarian cancer. J Cell Biochem. 2019; 120(8):13187-13201. DOI: 10.1002/jcb.28593. View

Palangi A, Shakhssalim N, Parvin M, Bayat S, Allameh A . Differential expression of S1P receptor subtypes in human bladder transitional cell carcinoma. Clin Transl Oncol. 2019; 21(9):1240-1249. DOI: 10.1007/s12094-019-02049-3. View

Saba J, Hla T . Point-counterpoint of sphingosine 1-phosphate metabolism. Circ Res. 2004; 94(6):724-34. DOI: 10.1161/01.RES.0000122383.60368.24. View

Roche W, Beasley R, Williams J, Holgate S . Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1989; 1(8637):520-4. DOI: 10.1016/s0140-6736(89)90067-6. View

Cyster J . Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol. 2005; 23:127-59. DOI: 10.1146/annurev.immunol.23.021704.115628. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

10.

Van Brocklyn J, Lee M, Menzeleev R, Olivera A, Edsall L, Cuvillier O . Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J Cell Biol. 1998; 142(1):229-40. PMC: 2133030. DOI: 10.1083/jcb.142.1.229. View

11.

Cheng N, Wang G . miR-133b, a microRNA targeting S1PR1, suppresses nasopharyngeal carcinoma cell proliferation. Exp Ther Med. 2016; 11(4):1469-1474. PMC: 4812514. DOI: 10.3892/etm.2016.3043. View

12.

Ge Z, Liu H, Ji T, Liu Q, Zhang L, Zhu P . Long non-coding RNA 00960 promoted the aggressiveness of lung adenocarcinoma via the miR-124a/SphK1 axis. Bioengineered. 2021; 13(1):1276-1287. PMC: 8805815. DOI: 10.1080/21655979.2021.1996507. View

13.

Atashbasteh M, Mortaz E, Mahdaviani S, Jamaati H, Allameh A . Expression levels of plasma exosomal miR-124, miR-125b, miR-133b, miR-130a and miR-125b-1-3p in severe asthma patients and normal individuals with emphasis on inflammatory factors. Allergy Asthma Clin Immunol. 2021; 17(1):51. PMC: 8276852. DOI: 10.1186/s13223-021-00556-z. View

14.

Kono Y, Nishiuma T, Nishimura Y, Kotani Y, Okada T, Nakamura S . Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1. Am J Respir Cell Mol Biol. 2007; 37(4):395-404. DOI: 10.1165/rcmb.2007-0065OC. View

15.

Oh S, Brandal S, Kapur R, Zhu Z, Takemoto C . Global microRNA expression is essential for murine mast cell development in vivo. Exp Hematol. 2014; 42(10):919-23.e1. PMC: 4250304. DOI: 10.1016/j.exphem.2014.07.266. View

16.

Vogt D, Stark H . Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism. Med Res Rev. 2016; 37(1):3-51. DOI: 10.1002/med.21402. View

17.

Wang E, He X, Zeng M . The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis. Front Pharmacol. 2019; 9:1504. PMC: 6338044. DOI: 10.3389/fphar.2018.01504. View

18.

Spiegel S, Milstien S . Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol. 2003; 4(5):397-407. DOI: 10.1038/nrm1103. View

19.

Fan A, Wang Q, Yuan Y, Cheng J, Chen L, Guo X . Liver X receptor-α and miR-130a-3p regulate expression of sphingosine 1-phosphate receptor 2 in human umbilical vein endothelial cells. Am J Physiol Cell Physiol. 2015; 310(3):C216-26. DOI: 10.1152/ajpcell.00102.2015. View

20.

Zhao Y, Ling Z, Hao Y, Pang X, Han X, Califano J . MiR-124 acts as a tumor suppressor by inhibiting the expression of sphingosine kinase 1 and its downstream signaling in head and neck squamous cell carcinoma. Oncotarget. 2017; 8(15):25005-25020. PMC: 5421905. DOI: 10.18632/oncotarget.15334. View